pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

4,973 catalysts · 4,686 phase readout · 2,347 8k filing · 285 earnings · 201 pdufa · 172 phase 2 completion · 73 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-20: 0 catalysts2026-07-21: 0 catalysts2026-07-22: 14 catalysts2026-07-23: 2 catalysts2026-07-24: 1 catalyst2026-07-25: 0 catalysts2026-07-26: 0 catalysts2026-07-27: 2 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 0 catalysts2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: earnings×type: phase readout×type: approval×clear all
type
  • phase readout4,686
  • 8k filing2,347
  • earnings285
  • pdufa201
  • phase 2 completion172
  • phase 1 completion73
phase 2 initiation
62
  • phase 1 initiation40
  • phase 1 2 completion35
  • phase 0 trial completion23
  • therapy area

    no tagged catalysts yet

    Date TBD

    50
    ›RECRUITINGphase readoutNCT06666348: Phase 1/2 Study of Mirdametinib + Vinblastine for Newly Diagnosed/Previously Untreated PLGG + Activation of MAPK

    Sponsor: St. Justine's Hospital. Phase: PHASE1. Conditions: Pediatric Low-grade Glioma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06471426: The Effect of Osteopathic Treatment on Craniocervico-Mandibular Dysfunction

    Sponsor: Edward Via Virginia College of Osteopathic Medicine. Phase: NA. Conditions: Headache, Neck Pain

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03328026: Combination Study of SV-BR-1-GM With Retifanlimab

    Sponsor: BriaCell Therapeutics Corporation. Phase: PHASE1. Conditions: Breast Cancer, Breast Neoplasm, Metastatic Breast Cancer, Breast Cancer Metastatic

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07593326: Midwife-Led Antenatal Perineal Massage Education in Primiparous Pregnant Women

    Sponsor: Atlas University. Phase: NA. Conditions: Pregnancy, Fear of Childbirth, Antenatal Education

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03555578: Specified Drug-Use Survey of Leuprorelin Acetate Injection Kit 11.25 mg "All-Case Investigation: Spinal and Bulbar Muscular Atrophy (SBMA)"

    Sponsor: Takeda. Phase: . Conditions: Spinal and Bulbar Muscular Atrophy

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05288985: Impact of Loco-regional Analgesia Following Placement of Erector Spinae Plane Catheter in Addition to Systemic Analgesia in Patients With Thoracic Trauma

    Sponsor: Centre Hospitalier Departemental Vendee. Phase: NA. Conditions: Trauma Abdomen

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04250077: We The Village Family Support Study

    Sponsor: We The Village, Inc.. Phase: NA. Conditions: Community Reinforcement And Family Training, Family Health, Substance-Related Disorders

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07444957: Safety and Effectiveness of the Crystalline Sirolimus-Eluting Device in Patients With Coronary Artery Disease

    Sponsor: Fundación Interhospitalaria para la Investigación Cardiovascular FIC. Phase: . Conditions: Coronary Arterial Disease (CAD), NSTEMI - Non-ST Segment Elevation Myocardial Infarction (MI), Stable Angina, Unstable Angina, NSTEMI, Drug Coated Balloon, ST-Elevation Myocardial Infarction, Silent Ischemia

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06605001: Development, Attention, and Inhibition Study

    Sponsor: University of California, Davis. Phase: NA. Conditions: The Ability to Delay Gratification

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07278375: Target Trial Emulation for Pharmacologic Treatment of Neonatal Opioid Withdrawal Syndrome

    Sponsor: HELP for NOWS Consortium. Phase: . Conditions: Neonatal Opioid Withdrawal Syndrome

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07412275: Microwave Intervention Under Local Anesthesia

    Sponsor: Koelis. Phase: NA. Conditions: Localised Prostate Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07369895: Clinical Study of O&D-001 Injection in the Treatment of Relapsed or Refractory Multiple Myeloma

    Sponsor: O&D BioTech Group CO., Limited. Phase: PHASE1. Conditions: Relapsed or Refractory Multiple Myeloma

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04773457: Neutrophil Phenotypic Profiling and Surgical Site Infections in Surgical Patients

    Sponsor: Boston Children's Hospital. Phase: . Conditions: Surgical Site Infection

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06463457: Comeback From Long coursE Androgen Deprivation Therapy (ADT) With RElugolix and Darolutamide (CLEARED)

    Sponsor: Atish Choudhury, MD. Phase: PHASE2. Conditions: Prostate Cancer, Advanced Prostate Cancer, Hormone Sensitive Prostate Cancer

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT06535477: Fall Risk Assessment With an Innovative Device for Quantifying Gait and Static Balance in Geriatric Consultation

    Sponsor: Gérond'if. Phase: NA. Conditions: Risk of Falling in the Elderly

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT07347457: Functional Rehabilitation Effects on Exercise-induced Hypoalgesia in Chronic Low Back Pain

    Sponsor: Clinique de la Mitterie. Phase: NA. Conditions: Low Back Pain

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07495553: Web-Based Filial Therapy In Pediatric Cancer

    Sponsor: serap güleç keskin. Phase: NA. Conditions: Pediatric Cancer, Parental Stress, Parenting Anxiety

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06075745: Cytomegalovirus (CMV) Vaccine in Orthotopic Liver Transplant Candidates

    Sponsor: National Institute of Allergy and Infectious Diseases (NIAID). Phase: PHASE2. Conditions: Liver Transplant

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07471672: Spot Compression Ultrasound Compared to Traditional Breast Ultrasound

    Sponsor: Duke University. Phase: NA. Conditions: Breast Mass

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06283472: Enhancing Prospective Thinking in Early Recovery (BEAM)

    Sponsor: Indiana University. Phase: NA. Conditions: Alcohol Use Disorder

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT05899595: Effects of a Personalized Physical Training to Reduce Fatigue

    Sponsor: Centre Hospitalier Universitaire de Saint Etienne. Phase: NA. Conditions: Fatigue Syndrome, Chronic

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT03513939: A Safety, Tolerability and Efficacy Study of Sernova's Cell Pouch™ for Clinical Islet Transplantation

    Sponsor: Sernova Biotherapeutics Inc.. Phase: PHASE1. Conditions: Type 1 Diabetes Mellitus

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05289739: Exercise Training in Childhood Cancer

    Sponsor: Johannes Gutenberg University Mainz. Phase: NA. Conditions: Pediatric Oncology

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06339177: Hemophagocytic Lymphohistiocytosis (HLH) Evaluation and Research of Clinical, ImmUnoLogic and TranscriptomE Study

    Sponsor: National Institute of Allergy and Infectious Diseases (NIAID). Phase: . Conditions: Lymphohistiocytosis, Hemophagocytic, Secondary Hemophagocytic Lymphohistiocytosis, Macrophage Activation Syndrome, Hyperinflammatory Syndromes

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07336277: Sleep Quality and the Efficacy of a Multimodal Sleep Pathway in Hospitalized Orthopedic Trauma Patients

    Sponsor: Emory University. Phase: PHASE3. Conditions: Orthopedic Trauma, Sleep Quality

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07238075: ADCX-020 for the Treatment of Patients With Locally Advanced or Metastatic Cancers

    Sponsor: Adcytherix SAS. Phase: PHASE1. Conditions: Advanced Malignancy, Advanced Solid Cancers, Metastatic Solid Tumors

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT06746675: Evaluating the Healthy Families PrEP Program for Women at Risk for HIV

    Sponsor: Yale University. Phase: NA. Conditions: HIV, Pregnancy, Pre-Exposure Prophylaxis of HIV Infection

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06807957: Inspiratory Muscle Training in Amateur CrossFit® Athletes

    Sponsor: Federal University of the Valleys of Jequitinhonha and Mucuri. Phase: NA. Conditions: Healthy

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06975657: Well-being Skills for Reentry

    Sponsor: University of Wisconsin, Madison. Phase: NA. Conditions: Formerly Incarcerated Adults

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06050577: The Effect of Oral Semaglutide on Bone Turnover in Patients With T2D: a Randomized Placebo-controlled Clinical Trial

    Sponsor: Odense University Hospital. Phase: PHASE2. Conditions: Type 2 Diabetes, Osteopenia

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT01980277: Phase Ib/II Study of LY2780301 in Combination With Weekly PACLITAXEL in HER2-metastatic Breast Cancer

    Sponsor: Institut Paoli-Calmettes. Phase: PHASE1. Conditions: Breast Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07028372: Long Term Follow-up of Cardiac Arrest Survivors Exposed to Ultra-rapid Cooling

    Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: . Conditions: Cardiac Arrest (CA), Resuscitated Sudden Cardiac Death, Post Cardiac Arrest Patient Who Was Treated by Hypothermia Protocol

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05359445: IMA401 TCER® in Recurrent and/or Refractory Solid Tumors, Alone or in Combination With a Checkpoint Inhibitor

    Sponsor: Immatics Biotechnologies GmbH. Phase: PHASE1. Conditions: Refractory Cancer, Recurrent Cancer, Solid Tumor, Adult, Cancer

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07585695: Coronary Artery Disease Screening in Patients With Chronic Kidney Disease

    Sponsor: University Hospital, Grenoble. Phase: . Conditions: Chronic Kidney Disease (CKD), Coronary Artery Disease (CAD)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05408845: Testing the Use of Ado-Trastuzumab Emtansine Compared to the Usual Treatment (Chemotherapy With Docetaxel Plus Trastuzumab) or Trastuzumab Deruxtecan for Recurrent, Metastatic, or Unresectable HER2-Expressing Salivary Gland Cancers

    Sponsor: NRG Oncology. Phase: PHASE2. Conditions: Metastatic Salivary Gland Carcinoma, Recurrent Salivary Gland Carcinoma, Stage III Major Salivary Gland Cancer AJCC v8, Stage IV Major Salivary Gland Cancer AJCC v8, Unresectable Salivary Gland Carcinoma

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT00515372: Depression Treatment and Screening in Ovarian Cancer Patients

    Sponsor: M.D. Anderson Cancer Center. Phase: PHASE1. Conditions: Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06814795: Medically Tailored Meals for Kids

    Sponsor: UNC Lineberger Comprehensive Cancer Center. Phase: NA. Conditions: Pediatric Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07542431: Impact of Dog Adoption and Training in Veterans With Post-traumatic Stress Symptoms and/or Other Mental Health Conditions

    Sponsor: Florida Atlantic University. Phase: NA. Conditions: Posttraumatic Stress Symptoms, Mental Health Conditions

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05763602: PVI to Prevent S. Aureus SSI After Fixation of HELEF (POTENT Study)

    Sponsor: Loreen Herwaldt. Phase: PHASE4. Conditions: Surgical Site Infection

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07550439: Effect of World Health Organization Labour Care Guide On Reducing Cesarean Section Rates

    Sponsor: Pak Emirates Military Hospital. Phase: NA. Conditions: Labour

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07602465: The Impact of Blood Pressure Variability During the Induction and Surgical Periods on Postoperative Acute Kidney Injury

    Sponsor: Zhongda Hospital. Phase: . Conditions: Acute Kidney Injury (AKI)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT03773965: A Study of Baricitinib in Participants From 1 Year to Less Than 18 Years Old With Juvenile Idiopathic Arthritis

    Sponsor: Eli Lilly and Company. Phase: PHASE3. Conditions: Juvenile Idiopathic Arthritis

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07413965: TAVR vs SAVR in Severe Bicuspid Aortic Stenosis

    Sponsor: Cedars-Sinai Medical Center. Phase: NA. Conditions: Bicuspid Aortic Valve Disease

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06923267: Ultrasound Evaluation of Cardiac Function During Spontaneous Breathing Trials

    Sponsor: Centre Hospitalier Régional d'Orléans. Phase: NA. Conditions: Weaning Invasive Mechanical Ventilation, Weaning-induced Pulmonary Edema, Weaning Failure of Mechanical Ventilation, Spontaneous Breathing Test, Intensive Care Units (ICUs)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07545967: Re-radiotherapy Combined With Chidamide for the Treatment of Recurrent Head and Neck Squamous Cell Carcinoma After Radiotherapy

    Sponsor: West China Hospital. Phase: PHASE1. Conditions: Head and Neck Squamous Cell Carcinoma HNSCC

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07196007: Leveraging Community-clinical Linkages to Address Unmet Social Needs for People With Diabetes

    Sponsor: Mary Lacy. Phase: NA. Conditions: Diabetes, Diabetes Mellitus

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT00862992: Safety, Pharmacokinetics and Efficacy Study of MP-214 in Patients With Schizophrenia

    Sponsor: Tanabe Pharma Corporation. Phase: PHASE2. Conditions: Schizophrenia

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07612592: The Clinical Application Study of Obinutuzumab in Pediatric Refractory Nephrotic Syndrome

    Sponsor: Children's Hospital of Chongqing Medical University. Phase: . Conditions: Primary Nephrotic Syndrome

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04972136: rTMS for Depression in Young Adults With Autism

    Sponsor: Centre for Addiction and Mental Health. Phase: NA. Conditions: Autism Spectrum Disorder, Major Depressive Disorder

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT01805336: Assessment of Attentional and Executive Disorders in Multiple Sclerosis Using Techniques of Virtual Reality

    Sponsor: University Hospital, Caen. Phase: NA. Conditions: Relapsing-Remitting Multiple Sclerosis

    full page →ctgov ↗
    ← prev
    page 45 of 100
    next →